This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lozniewski, A.
Right arrow Articles by Mory, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lozniewski, A.
Right arrow Articles by Mory, F.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Clostridium Difficile Infections
*Diarrhea

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, May 2001, p. 1996-1998, Vol. 39, No. 5
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.5.1996-1998.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Laboratory Diagnosis of Clostridium difficile-Associated Diarrhea and Colitis: Usefulness of Premier Cytoclone A+B Enzyme Immunoassay for Combined Detection of Stool Toxins and Toxigenic C. difficile Strains

Alain Lozniewski,1 Christian Rabaud,2 Emmanuelle Dotto,1 Michele Weber,1 and Francine Mory1,*

Laboratoire de Bactériologie, Hôpital Central, Centre Hospitalier et Universitaire, 54035 Nancy Cedex,1 and Service de Maladies Infectieuses et Tropicales, Hôpital de Brabois, Centre Hospitalier et Universitaire, 54500 Vandoeuvre,2 France

Received 27 October 2000/Returned for modification 20 December 2000/Accepted 5 February 2001

Detection of Clostridium difficile toxins A and B in stools by Premier Cytoclone A+B enzyme immunoassay (EIA) was compared with detection by stool culture for C. difficile followed by detection of toxigenic isolates using the same EIA. Chart reviews were performed to evaluate the likelihood of C. difficile-associated diarrhea and colitis (CADC) for all patients with at least one positive toxin assay. While the toxins were detected in 58 of 85 consecutive CADC patients by both assays, CADC in 5 patients was detected only by stool toxin assay, and in 22 patients CADC was detected only by toxigenic culture. Our results suggest that for laboratories using a rapid toxin A+B EIA, direct toxin detection in stools should be combined with toxigenic culture in cases in which there is a negative stool toxin assay.

* Corresponding author. Mailing address: Laboratoire de Bactériologie, Hôpital Central, 29, Avenue du Maréchal de Lattre de Tassigny, 54035 Nancy Cedex, France. Phone: (33) 3-83-85-14-34. Fax: (33) 3-83-85-26-73. E-mail: f.mory{at}chu-nancy.fr.

Journal of Clinical Microbiology, May 2001, p. 1996-1998, Vol. 39, No. 5
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.5.1996-1998.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Monaghan, T, Boswell, T, Mahida, Y R (2009). Recent advances in Clostridium difficile-associated disease. Postgrad. Med. J. 85: 152-162 [Abstract] [Full Text]  
  • She, R. C., Durrant, R. J., Petti, C. A. (2009). Evaluation of Enzyme Immunoassays to Detect Clostridium difficile Toxin From Anaerobic Stool Culture. Am J Clin Pathol 131: 81-84 [Abstract] [Full Text]  
  • Monaghan, T, Boswell, T, Mahida, Y R (2008). Recent advances in Clostridium difficile-associated disease. Gut 57: 850-860 [Abstract] [Full Text]  
  • Garcia, C., Samalvides, F., Vidal, M., Gotuzzo, E., Dupont, H. L. (2007). Epidemiology of Clostridium difficile Associated Diarrhea in a Peruvian Tertiary Care Hospital. Am J Trop Med Hyg 77: 802-805 [Abstract] [Full Text]  
  • Crabtree, T., Aitchison, D., Meyers, B. F., Tymkew, H., Smith, J. R., Guthrie, T. J., Munfakh, N., Moon, M. R., Pasque, M. K., Lawton, J., Moazami, N., Damiano, R. J. Jr (2007). Clostridium Difficile in Cardiac Surgery: Risk Factors and Impact on Postoperative Outcome. Ann. Thorac. Surg. 83: 1396-1402 [Abstract] [Full Text]  
  • Surowiec, D., Kuyumjian, A. G, Wynd, M. A, Cicogna, C. E (2006). Past, Present, and Future Therapies for Clostridium difficile-Associated Disease. The Annals of Pharmacotherapy 40: 2155-2163 [Abstract] [Full Text]  
  • Garey, K. W, Graham, G., Gerard, L., Dao, T., Jiang, Z. D., Price, M., DuPont, H. L (2006). Prevalence of Diarrhea at a University Hospital and Association with Modifiable Risk Factors. The Annals of Pharmacotherapy 40: 1030-1034 [Abstract] [Full Text]  
  • Delmee, M., Van Broeck, J., Simon, A., Janssens, M., Avesani, V. (2005). Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture. J Med Microbiol 54: 187-191 [Abstract] [Full Text]  
  • Lemee, L., Dhalluin, A., Testelin, S., Mattrat, M.-A., Maillard, K., Lemeland, J.-F., Pons, J.-L. (2004). Multiplex PCR Targeting tpi (Triose Phosphate Isomerase), tcdA (Toxin A), and tcdB (Toxin B) Genes for Toxigenic Culture of Clostridium difficile. J. Clin. Microbiol. 42: 5710-5714 [Abstract] [Full Text]  
  • Johal, S S, Hammond, J, Solomon, K, James, P D, Mahida, Y R (2004). Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy. Gut 53: 673-677 [Abstract] [Full Text]  
  • Turgeon, D. K., Novicki, T. J., Quick, J., Carlson, L., Miller, P., Ulness, B., Cent, A., Ashley, R., Larson, A., Coyle, M., Limaye, A. P., Cookson, B. T., Fritsche, T. R. (2003). Six Rapid Tests for Direct Detection of Clostridium difficile and Its Toxins in Fecal Samples Compared with the Fibroblast Cytotoxicity Assay. J. Clin. Microbiol. 41: 667-670 [Abstract] [Full Text]  
  • Bartlett, J. G. (2002). Antibiotic-Associated Diarrhea. NEJM 346: 334-339 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»